SciSparc licenses SCI-160 pain drug program to Polyrizon. TIME TO BUY. SHOULD HIT 3 DOLLARS AND ABOVE.
$SciSparc (SPRC.US)$ SciSparc licenses SCI-160 pain drug program to Polyrizon. TIME TO BUY. SHOULD HIT 3 DOLLARS AND ABOVE.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Dannywl : I think if you find the source better post here, or else not enough to persuade other to get in![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
EZ_money : keep buying
EZ_money : break .50
实发 : This news has been around for a few days